HF Enterprises, Inc. (HFEN)
| Market Cap | 57.42M |
| Revenue (ttm) | 11.65M |
| Net Income (ttm) | -842,261 |
| Shares Out | 8.60M |
| EPS (ttm) | -0.10 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | January 15 |
| Last Price | $6.57 |
| Previous Close | $6.33 |
| Change ($) | 0.24 |
| Change (%) | 3.85% |
| Day's Open | 6.38 |
| Day's Range | 6.23 - 6.91 |
| Day's Volume | 70,065 |
| 52-Week Range | 4.61 - 6.98 |
News
There are no news available yet.
About HFEN
HF Enterprises, through its subsidiaries, engages in property development, digital transformation technology, and biohealth activities in the United States, Singapore, Hong Kong, and Australia. The company owns, operates, and manages real estate development projects, as well as lease units; and provides consulting, implementation, and development services related to digital transformation of enterprises. It also focuses on the research, development, and sale of Linebacker, a therapeutic drug platform; Laetose, a functional sugar substitute; and... [Read more...]
| Industry Real Estate-Development | IPO Date Nov 24, 2020 |
| CEO Chan Heng Fai | Employees 20 |
| Stock Exchange NASDAQ | Ticker Symbol HFEN |
Financial Performance
In 2019, HF Enterprises's revenue was $24.26 million, an increase of 19.02% compared to the previous year's $20.38 million. Losses were -$5.23 million, 4.82% more than in 2018.